EP3191120
NOTKUN IL-17 BLOKKA TIL AÐ HINDRA FRAMGANG VEFRÆNNA SKEMMDA HJÁ SJÚKLINGUM MEÐ SÓRALIÐAGIGT
:
EP einkaleyfi í gildi á Íslandi:
8.9.2015:
10.4.2024:
15767597.6
:
16.7.2024:
15.9.2024
:
7.9.2035:
7.9.2025:
30.9.2025
:
USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS
8.9.2015
10.4.2024
16.7.2024
15.9.2024
7.9.2025
:
NOVARTIS AG:
Lichtstrasse 35, 4056 Basel, CH
:
MPOFU, Shephard:
4002 Basel, CH
:
RICHARDS, Hanno:
4002 Basel, CH
:
LIGOZIO, Gregory:
East Hanover, NJ 07936, US
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
201462048512 P:
10.9.2014:
US
:
IB2015056871:
8.9.2015
:
A61K 39/00, C07K 16/24
: 10
: 26.8.2024
: 7.9.2025
: Zacco Denmark A/S